Genomic Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand
Genomische Epidemiologie von Carbapenem-resistentem Acinetobacter baumannii, isoliert von Patient:innen auf Intensivstationen in Netzwerkkrankenhäusern in Südthailand
Antibiotics · 28.01.2026 · 15 (2) · 133
DOI: 10.3390/antibiotics15020133 ↗Auf einen Blick
Die Studie analysierte 294 CRAB-Isolate aus 7 Krankenhäusern in Südthailand. ST2 war die häufigste und dominanteste Linie und war mit hoher Resistenz und Virulenz verbunden.
Fragestellung
Wie ist die genomische Epidemiologie von CRAB-Isolaten in einem Krankenhausnetzwerk in Südthailand?
Methode
Genomische Analyse von 294 CRAB-Isolaten aus 7 Krankenhäusern; 224 WGS-Datensätze aus einer früheren Studie und 70 zusätzliche Isolate; Proben aus 2019 bis 2020.
Ergebnisse
Am häufigsten stammten die Isolate aus Sputum. ST2 war der häufigste Sequence Type und dominierte über mehrere große Krankenhäuser. Clade B (ST2) war mit Pneumonie sowie Blutstrom-, Haut- und Weichteilinfektionen verbunden.
Schlussfolgerung der Autor:innen
Die Analyse zeigte eine weite Verbreitung einer ST2-CRAB-Linie mit erhöhter Resistenz und Virulenz im Krankenhausnetzwerk; genomisch gestützte Surveillance ist wichtig zur Kontrolle der Ausbreitung.
Kernaussagen
- 294 Isolate aus 7 Krankenhäusern wurden genomisch analysiert
- ST2 war die häufigste und vielseitigste CRAB-Linie
- blaOXA-23 dominierte unter den Resistenz- und Plasmidkombinationen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 28.01.2026. Verfasst von Arnon Chukamnerd und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Disease, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University.
Themen: Intensivpflege
Abstract (Originalsprache)
Background/Objectives: Carbapenem-resistant Acinetobacter baumannii (CRAB) is classified as an urgent-threat pathogen because of its resistance to nearly all available antibiotics, resulting in high morbidity and mortality rates. However, data on the molecular epidemiology of CRAB isolates in southern Thailand are limited. This study aimed to investigate the genomic epidemiology of CRAB isolates within a hospital network in lower southern Thailand.
Methods
Whole-genome sequencing data of CRAB clinical isolates (n = 224) were obtained from a previous study. Additional isolates (n = 70) were included, for which genomic DNA was extracted and sequenced. In total, 294 isolates were collected from patients across seven hospitals in southern Thailand between 2019 and 2020. Their genomes were analyzed using several bioinformatic tools.
Results
A high proportion of isolates were obtained from sputum samples of patients with CRAB infection or colonization. Sequence type (ST) 2 was the most frequent ST and was classified in the quadrant with high resistance and virulence. The Sankey diagram showed that ST2 was the dominant and most versatile CRAB lineage circulating across major hospitals, commonly associated with pneumonia, and that diverse resistance genes and plasmid combinations were dominated by blaOXA-23. The core single-nucleotide polymorphism (SNP)-based phylogenetic tree revealed clades A1 (ST215), A2 (multiple STs), and B (ST2). Bloodstream, skin, and soft tissue infections were predominantly observed in clade B.
Conclusions
Our analysis revealed widespread circulation of a high-risk ST2 CRAB lineage with enhanced resistance and virulence across hospital networks in the studied region, highlighting the importance of genomics-informed surveillance for controlling CRAB dissemination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Disease, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
- Department of Biomedical Sciences and Biomedical Engineering, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
- Division of Biological Science, Faculty of Science, Prince of Songkla University, Songkhla 90110, Thailand.
- Pornchai Matangkasombut Center for Microbial Genomics, Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
ORCID-Profile: Arnon Chukamnerd, Komwit Surachat, Rattanaruji Pomwised, Prasit Palittapongarnpim, Kamonnut Singkhamanan, Sarunyou Chusri
Förderung
- National Science, Research and Innovation Fund (NSRF) and Prince of Songkla University
Zitieren
APA
Chukamnerd, A., Surachat, K., Pomwised, R., Palittapongarnpim, P., Singkhamanan, K., & Chusri, S. (2026). Genomic Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand. Antibiotics, 15(2), 133. https://doi.org/10.3390/antibiotics15020133
Vancouver
Chukamnerd A, Surachat K, Pomwised R, Palittapongarnpim P, Singkhamanan K, Chusri S. Genomic Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand. Antibiotics. 2026;15(2):133. doi:10.3390/antibiotics15020133
BibTeX
@article{Chukamnerd2026,
author = {Chukamnerd, Arnon and Surachat, Komwit and Pomwised, Rattanaruji and Palittapongarnpim, Prasit and Singkhamanan, Kamonnut and Chusri, Sarunyou},
title = {Genomic Epidemiology of Carbapenem-Resistant Acinetobacter baumannii Isolated from Patients Admitted to Intensive Care Units in Network Hospitals in Southern Thailand},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {2},
pages = {133},
doi = {10.3390/antibiotics15020133}
}
EUVIMED